|
Thursday, December 9, 2021, San Antonio, TX, 7:00 PM – 8:45 PM Central Time (8:00 PM – 9:45 PM Eastern Time)
What Clinicians Want to Know: Addressing Current Questions and Controversies in the Management of Triple-Negative Breast Cancer (Part 3 of a 3-Part Series)A CME Satellite Symposium Held in Conjunction with SABCS®2021
Location
San Antonio Marriott Rivercenter 101 Bowie St San Antonio, TX 78205 Hotel Phone: (210) 223-1000 Program Schedule — Central Time 6:30 PM – 7:00 PM — Registration and Dinner 7:00 PM – 8:45 PM — Educational Meeting Meeting Room Grand Ballroom G-M (3rd floor) This event will also be webcast live. Please see Registration tab for details. Faculty
Sara Hurvitz, MD Professor of Medicine David Geffen School of Medicine at UCLA Director, Breast Cancer Clinical Research Program Co-Director, Santa Monica-UCLA Outpatient Oncology Practice Santa Monica, California Rita Nanda, MD Director, Breast Oncology Associate Professor of Medicine Section of Hematology/Oncology The University of Chicago Chicago, Illinois Melinda Telli, MD Associate Professor of Medicine Stanford University School of Medicine Director, Breast Cancer Program Stanford Cancer Institute Stanford, California Moderator Hope S Rugo, MD Professor of Medicine Director, Breast Oncology and Clinical Trials Education University of California, San Francisco Helen Diller Family Comprehensive Cancer Center San Francisco, California This activity is supported by educational grants from AstraZeneca Pharmaceuticals LP, Daiichi Sankyo Inc, Gilead Sciences Inc and Merck.
Program Schedule — Central Time 6:30 PM – 7:00 PM — Registration and Dinner 7:00 PM – 8:45 PM — Educational Meeting MODULE 1: Promising Therapeutic Strategies for Patients with Localized Triple-Negative Breast Cancer (TNBC) MODULE 2: Optimal Integration of Immune Checkpoint Inhibitors into the Management of Metastatic TNBC (mTNBC) MODULE 3: Current and Future Role of PARP Inhibitors for Patients with mTNBC MODULE 4: Other Novel Treatment Options and Investigational Strategies for TNBC Target Audience
CME Credit Form FACULTY — The following faculty reported relevant financial relationships with ineligible entities: Dr Hurvitz — Contracted Research Paid to Institution: Ambrx, Amgen Inc, Arvinas, AstraZeneca Pharmaceuticals LP, Bayer HealthCare Pharmaceuticals, CytomX Therapeutics, Daiichi Sankyo Inc, Dignitana AB, Genentech, a member of the Roche Group, Gilead Sciences Inc, GlaxoSmithKline, Immunomedics Inc, Lilly, MacroGenics Inc, Novartis, OBI Pharma Inc, Pfizer Inc, Phoenix Molecular Designs, Pieris Pharmaceuticals Inc, Puma Biotechnology Inc, Radius Health Inc, Sanofi Genzyme, Seagen Inc, Zymeworks Inc. Dr Nanda — Advisory Committee: Cardinal Health, Clovis Oncology, FUJIFILM Pharmaceuticals USA Inc, G1 Therapeutics Inc, Genentech, a member of the Roche Group, Gilead Sciences Inc, Immunomedics Inc, iTeos Therapeutics, MacroGenics Inc, Merck, OncoSec Medical, Pfizer Inc, Seagen Inc; Contracted Research: Arvinas, AstraZeneca Pharmaceuticals LP, Celgene Corporation, Corcept Therapeutics, Genentech, a member of the Roche Group, Gilead Sciences Inc, Immunomedics Inc, Merck, OBI Pharma Inc, Odonate Therapeutics, OncoSec Medical, Pfizer Inc, Seagen Inc, Taiho Oncology Inc; Data and Safety Monitoring Board/Committee: G1 Therapeutics Inc. Dr Telli — Advisory Committee: AbbVie Inc, Aduro Biotech, AstraZeneca Pharmaceuticals LP, Blueprint Medicines, Celgene Corporation, Daiichi Sankyo Inc, G1 Therapeutics Inc, Immunomedics Inc, Lilly, Natera Inc, Novartis, OncoSec Medical, Pfizer Inc, Sanofi Genzyme; Consulting Agreements: Genentech, a member of the Roche Group, Guardant Health, Merck; Contracted Research: AbbVie Inc, AstraZeneca Pharmaceuticals LP, Bayer HealthCare Pharmaceuticals, Biothera Pharmaceuticals Inc, Calithera Biosciences, EMD Serono Inc, Genentech, a member of the Roche Group, Merck, OncoSec Medical, Pfizer Inc, PharmaMar, Tesaro, A GSK Company; Data and Safety Monitoring Board/Committee: G1 Therapeutics Inc, Immunomedics Inc.MODERATOR — Hope S Rugo, MD – Consulting Agreement: Samsung Bioepis (limited consulting); Contracted Research: AstraZeneca Pharmaceuticals LP, Daiichi Sankyo Inc, Eisai Inc, Genentech, a member of the Roche Group, Immunomedics Inc, Lilly, MacroGenics Inc, Merck, Novartis, OBI Pharma Inc, Odonate Therapeutics, Pfizer Inc, Seagen Inc, Sermonix Pharmaceuticals; Honoraria: Mylan, Puma Biotechnology Inc; Travel: AstraZeneca Pharmaceuticals LP, Daiichi Sankyo Inc, MacroGenics Inc, Merck, Mylan, Novartis, Pfizer Inc. SLIDES CONTRIBUTOR - Professor Peter Schmid, FRCP, MD, PhD — Consulting Agreements: AstraZeneca Pharmaceuticals LP, Bayer HealthCare Pharmaceuticals, Boehringer Ingelheim Pharmaceuticals Inc, Celgene Corporation, Eisai Inc, Merck, Novartis, Pfizer Inc, Puma Biotechnology Inc, Roche Laboratories Inc; Contracted Research: Astellas, AstraZeneca Pharmaceuticals LP, Genentech, a member of the Roche Group, Medivation Inc, a Pfizer Company, Novartis, OncoGenex Pharmaceuticals Inc, Roche Laboratories Inc; Spouse Employment/Salary: Roche Laboratories Inc. Research To Practice CME Planning Committee Members, Staff and Reviewers — Planners, scientific staff and independent reviewers for Research To Practice have no relevant conflicts of interest to disclose. SupportersThis activity is supported by educational grants from AstraZeneca Pharmaceuticals LP, Daiichi Sankyo Inc, Gilead Sciences Inc and Merck. San Antonio Marriott Rivercenter Thank you for your interest in our CME program. At this time online preregistration is closed for this event. SEATS ARE STILL AVAILABLE FOR THE SESSION. Our Onsite Registration Desk will be open at 6:30 PM on Thursday, December 9th. If you are interested in attending, please visit our registration desk located outside the Grand Ballroom G-M (Third Floor) of the Marriott Rivercenter hotel (101 Bowie St) within walking distance of the Henry B Gonzalez Convention Center. If you have any questions, please feel free to contact us via email at Meetings@ResearchToPractice.com, or call (800) 233-6153. NOTICE: Registration for this event is independent of registration for the SABCS Conference. Registration for live broadcast
Please note we will stream this event over Zoom. After registering you will receive a separate confirmation from Zoom with the viewing instructions. Registration for Webcast »Registration for groups
If you are registering a group (more than 1 person) for this event, please contact us at
Meetings@ResearchToPractice.com or (800) 233-6153.
To ensure seating and meal service, please check in at our onsite registration desk at least 30 minutes before the start of the meeting. We cannot guarantee seating after the start of the program.Photography and/or video recording may be taken during the educational program by Research To Practice and used in future educational offerings. Research To Practice fully complies with the legal requirements of the ADA. If you are in need of assistance (ie, physical, dietary, et cetera), please contact us prior to the event at (800) 233-6153.
|